Versigent (NYSE:VGNT) Issues Earnings Results

Versigent (NYSE:VGNT) posted its earnings results on Tuesday. The company reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.34, Zacks reports.

Here are the key takeaways from Versigent’s conference call:

• Versigent reported strong second-quarter results, with net sales up 11% year over year to $2.4 billion, adjusted EBITDA up 25% to $272 million, and margin expanding 120 basis points to 11.1%. Underlying adjusted sales growth was approximately 5%, outpacing relatively flat-to-down global automotive production.
• The company cited robust commercial momentum, including $2.8 billion in second-quarter bookings and 39 large-scale program launches with more than 99% quality and on-time delivery. Growth was particularly strong in the Americas and Asia-Pacific, supported by customer launches and China-related vehicle exports.
• Versigent raised its 2026 sales guidance to $9.4 billion-$9.6 billion, primarily due to higher copper pass-throughs and favorable foreign exchange, but maintained adjusted EBITDA guidance of $950 million-$1.03 billion because those macro benefits are not expected to materially improve profitability. The company also reaffirmed free cash flow guidance of $200 million-$300 million.
• Management expects second-half pressure from lower global automotive production, customer-specific schedule reductions, softer EMEA demand, and temporary volume and absorption impacts from an unusually high number of program launches. European adjusted sales declined 11% in the quarter, prompting targeted actions to improve regional competitiveness.
• The company initiated a quarterly dividend of $0.13 per share and has $250 million remaining under its share-repurchase authorization, supported by its projected cash generation and approximately $1 billion of cumulative free cash flow from 2026 through 2028. Management also identified commercial vehicles, agriculture, battery energy storage, and robotics as potential longer-term growth opportunities not included meaningfully in its 2028 outlook.

Versigent Trading Up 8.0%

VGNT traded up $3.35 during trading on Tuesday, reaching $45.39. 251,434 shares of the stock were exchanged, compared to its average volume of 2,062,580. The business’s 50 day moving average price is $43.28. Versigent has a twelve month low of $26.34 and a twelve month high of $50.88.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on VGNT. BNP Paribas Exane assumed coverage on shares of Versigent in a report on Tuesday, April 28th. They issued an “outperform” rating and a $41.00 price objective on the stock. Wells Fargo & Company increased their target price on shares of Versigent from $42.00 to $48.00 and gave the stock an “overweight” rating in a report on Thursday, June 25th. UBS Group decreased their target price on shares of Versigent from $58.00 to $55.00 and set a “buy” rating for the company in a research report on Thursday, July 9th. Zacks Research upgraded shares of Versigent from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 2nd. Finally, Fox Advisors raised shares of Versigent to a “strong-buy” rating in a research report on Tuesday, April 7th. Three research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $49.67.